mifepristone has been researched along with 17-alpha-hydroxyprogesterone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Alameh, G; Barret, R; Beltran, S; Cuilleron, CY; de Ravel, MR; Dumontet, C; El Jawad, L; Emptoz-Bonneton, A; Grenot, C; Le Borgne, M; Lomberget, T; Mahiout, Z; Mappus, E; Matera, EL; Melikian, M; Pugeat, M; Rocheblave, L; Walchshofer, N | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Carlström, K; Kindahl, H; Olund, A; Somell, C | 1 |
| King, I; Sartorelli, AC; Violette, SM | 1 |
| Doering, K; Eliason, HC; Marks, BD; Qadir, N; Shekhani, MS; Vogel, KW | 1 |
| Garfield, RE; Hankins, GD; Jain, S; Moore, G; Romero, R; Ruddock, NK; Shi, SQ | 1 |
| Balducci, J; Garfield, RE; Kuon, RJ; Maul, H; Shi, L; Shi, SQ; Sohn, C | 1 |
| Asser, L; Delemer, B; Hescot, S; Lombès, M; Trabado, S; Viengchareun, S | 1 |
10 other study(ies) available for mifepristone and 17-alpha-hydroxyprogesterone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Synthesis of new steroidal inhibitors of P-glycoprotein-mediated multidrug resistance and biological evaluation on K562/R7 erythroleukemia cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Survival; Crystallography, X-Ray; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Models, Molecular; Molecular Conformation; Progesterone; Tumor Cells, Cultured | 2015 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Reproductive hormones during termination of early pregnancy with mifepristone.
Topics: 17-alpha-Hydroxyprogesterone; Abortion, Induced; Chorionic Gonadotropin; Dinoprost; Estradiol; Female; Humans; Hydroxyprogesterones; Mifepristone; Pregnancy; Progesterone | 1990 |
Induction of the terminal differentiation of a human squamous cell carcinoma by steroids with glucocorticoid activity.
Topics: 17-alpha-Hydroxyprogesterone; Androstanols; Carcinoma, Squamous Cell; Cell Differentiation; Desoxycorticosterone; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Hydrocortisone; Hydroxyprogesterones; In Vitro Techniques; Mifepristone; Mineralocorticoids; Neovascularization, Pathologic; Progesterone; Tretinoin; Tumor Cells, Cultured | 1989 |
Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurements.
Topics: 17-alpha-Hydroxyprogesterone; Binding, Competitive; Drug Evaluation, Preclinical; Fluorescence Polarization; Fluorescent Dyes; Hormone Antagonists; Humans; Ligands; Mifepristone; Progesterone; Receptors, Progesterone; Reproducibility of Results | 2005 |
Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Inhibitory Concentration 50; Menstruation-Inducing Agents; Mifepristone; Myometrium; Progesterone; Progestins; Uterine Contraction | 2008 |
A novel optical method to assess cervical changes during pregnancy and use to evaluate the effects of progestins on term and preterm labor.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Cervix Uteri; Female; Labor, Obstetric; Mifepristone; Obstetric Labor, Premature; Photography; Pregnancy; Pregnancy Outcome; Progesterone; Progestins; Rats; Rats, Sprague-Dawley | 2011 |
Autocrine positive regulatory feedback of glucocorticoid secretion: glucocorticoid receptor directly impacts H295R human adrenocortical cell function.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Autocrine Communication; Cell Line, Tumor; Cortodoxone; Dexamethasone; Gene Expression Regulation; Gene Knockdown Techniques; Glucocorticoids; Hormone Antagonists; Humans; Hydrocortisone; Mifepristone; Receptors, Glucocorticoid | 2014 |